Hyperforin content and chronic St. John’s wort interactions with CYP3A probes

A review linked the magnitude of metabolic induction to the composition of the herbal preparation.

A product-dependent mechanism

The review describes activation of pathways that induce drug-metabolizing enzymes, particularly CYP3A4, and transporters after St. John’s wort exposure. It emphasizes the relationship between induction and hyperforin content. Midazolam and alprazolam appear among the probes or substrates discussed in the underlying interaction literature.

The review also reports limited or absent clinically relevant interactions in selected studies using low-hyperforin preparations. That observation concerns those products and regimens, not every supplement sold under the same plant name.

Exposure duration is part of the mechanism

Enzyme induction after repeated use is a different question from an immediate pharmacodynamic interaction after a single dose. Product composition, duration, and time since discontinuation belong in an exposure reconstruction.

This review does not provide a universal adjustment for a benzodiazepine concentration or a guarantee that a low-hyperforin product has no interactions. It supports preparation-specific interpretation and distinguishes a proposed mechanism from its measured magnitude in any particular patient.

Source paper

Original analysis of the supplied journal article, identified as PMC7056460.

Related research

• Oral and Intravenous Midazolam Probes Answered Different Questions in a Napabucasin Study
• A Pill Resembling Alprazolam Is Not Proof of Alprazolam Content